| EdU | 5-Ethynyl-2′-deoxyuridine |
| Bcl-2 | B-cell lymphoma 2 |
| CSRAs | Cell culture chemotherapy sensitive and resistant assays |
| CDXs | Cell-Derived-Xenografts |
| CRC | Colorectal cancer |
| dpf | Days post-fertilization |
| DBP | Dynamic BH3 profiling |
| EGFR | Epidermal growth factor receptor |
| ER | Estrogen receptor |
| ECM | Extracellular matrix |
| ESMO | European Society for Medical Oncology |
| FDA | Food and Drug Administration |
| HER2 | Herceptin-2 |
| HLA | Human leukocyte antigen |
| MOMP | Mitochondrial Outer Membrane Permeabilization |
| mPDX | Mouse Patient-Derived Xenografts |
| NCCN | National Comprehensive Cancer Network |
| PDXs | Patient-Derived Xenografts |
| PVS | Perivitelline space |
| pHH3 | Phospho-histone H3 |
| PARP | Poly ADP ribose polymerase |
| PD-1 | Programmed cell death-1 |
| prkdc | Protein kinase DNA-activated catalytic polypeptide |
| RMS | Rhabdomyosacoma |
| TME | Tumor microenvironment |
| zPDX | Zebrafish Patient-Derived Xenografts |